Aid in the prevention of disease and mortality caused by 4 virulent Leptospira serovars21
Protects against liver dysfunction and thrombocytopenia1
The only vaccine indicated to protect against mortality and leptospiruria
Proven safe and well tolerated in multiple studies1
Available in both a stand-alone and combination formulation (DAPPv)
Shown to be effective against disease and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, or L. grippotyphosa.
Prevents leptospiruria associated with L. grippotyphosa, L. canicola, or L. icterohaemorrhagiae.
Aids in the prevention of leptospiruria associated with L. pomona.
Recommended for use in healthy dogs 8 weeks of age or older.
Unmatched Protection of Nobivac® Lepto4:Two Critical Indications
1. SHEDDING: DEFENSE AGAINST URINARY SHEDDING CAUSED BY 4 KEY LEPTOSPIRA SEROVARS
PREVENT URINARY SHEDDING OF LEPTOSPIRES22
A key objective of vaccination is to prevent urinary shedding of leptospires, which has potential zoonotic risk:22,23
0% of dogs vaccinated with Nobivac® Canine 1-DAPPv+L4 developed leptospiruria
All of the control dogs challenged with L. canicola and L. grippotyphosa, 80% of control dogs challenged with L. icterohaemorrhagiae, and 50% of control dogs challenged with L. pomona developed leptospiruria
Nobivac® Lepto4 is shown to be effective against leptospiruria associated with
NOBIVAC LEPTO4 IS THE CLEAR CHOICE WHEN COMPARED WITH OTHER 4-WAY LEPTOSPIROSIS VACCINES24-27